American Journal of Cardiology

Article	Citations
Meta-analysis of Effect of Statins in Patients with COVID-19	133
Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients	127
Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction	74
COVID-19 Vaccine and Myocarditis	64
Meta-Analysis of Inclisiran for the Treatment of Hypercholesterolemia	59
Right Ventricular–Pulmonary Arterial Coupling in Secondary Tricuspid Regurgitation	56
Usefulness of Elevated Troponin to Predict Death in Patients With COVID-19 and Myocardial Injury	54
Meta-Analysis of the Effect of Aspirin on Mortality in COVID-19	52
Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors	49
Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis	46
Validation of an Integrated Risk Tool, Including Polygenic Risk Score, for Atherosclerotic Cardiovascular Disease in Multiple Ethnicities and Ancestries	46
Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease	39
Arrhythmogenic Right Ventricular Cardiomyopathy Presenting as Clinical Myocarditis in Women	37
Sleep Duration and Cardiovascular Health in a Representative Community Population (from NHANES, 2005 to 2016)	37
Meta-Analysis of Gender Disparities in In-hospital Care and Outcomes in Patients with ST-Segment Elevation Myocardial Infarction	35
Prevalence and Outcomes of Acute Ischemic Stroke Among Patients ≤50 Years of Age With Laboratory Confirmed COVID-19 Infection	35
Cardiac Injury Patterns and Inpatient Outcomes Among Patients Admitted With COVID-19	34
Meta-Analysis Comparing Cryoballoon Versus Radiofrequency as First Ablation Procedure for Atrial Fibrillation	34
Lipid Profile and Subsequent Cardiovascular Disease among Young Adults Aged < 50 Years	33
Prognostic Usefulness of Myocardial Work in Patients With Heart Failure and Reduced Ejection Fraction Treated by Sacubitril/Valsartan	33
Acute Myocardial Infarction Within 24 Hours After COVID-19 Vaccination	33
Meta-analysis Examining the Usefulness of Angiotensin Receptor blockers for the Prevention of Aortic Root Dilation in Patients With the Marfan Syndrome	33
Pattern and Impact of Off-label Underdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Who are Indicated for Standard Dosing	33
Valve-in-Valve Transcatheter Implantation Versus Redo Surgical Aortic Valve Replacement	33
Burden of Arrhythmias in Acute Myocardial Infarction Complicated by Cardiogenic Shock	32

Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension S	31
Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019	31
Prognostic Value of Elevated Cardiac Troponin I in Hospitalized Covid-19 Patients	31
Prognostic Value of Left Ventricular Global Longitudinal Strain in COVID-19	31
Meta-Analysis of Atrial Fibrillation in Patients With COVID-19	31
Ventricular Arrhythmia and Life-Threatening Events in Patients With Repaired Tetralogy of Fallot	30
Socioeconomic Status and Differences in the Management and Outcomes of 6.6 Million US Patients With Acute Myocardial Infarction	30
Effect of a Multidisciplinary Pulmonary Embolism Response Team on Patient Mortality	30
Use of Flecainide for the Treatment of Atrial Fibrillation	30
Meta-analysis of Cardiovascular Events and Related Biomarkers Comparing Survivors Versus Non-survivors in Patients With COVID-19	29
Cardiac Involvment in COVID-19–Related Acute Respiratory Distress Syndrome	29
Sudden Unexpected Death Due to Myocarditis in Young People, Including Athletes	28
Limitations of Randomized Clinical Trials	28
Comparison of the Efficacy and Safety of Sacubitril/Valsartan versus Ramipril in Patients With ST-Segment Elevation Myocardial Infarction	27
Meta-analysis of the Usefulness of Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction	27
Inappropriate Dosing of Direct Oral Anticoagulants in Patients with Atrial Fibrillation	27
Meta-Analysis of Bioprosthetic Valve Thrombosis After Transcatheter Aortic Valve Implantation	27
Validation of Acute Ischemic Stroke Codes Using the International Classification of Diseases Tenth Revision	26
Catheter Ablation for Atrial Fibrillation in Patients With Concurrent Heart Failure	26
Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Atrial Fibrillation	26
Prevention and Treatment of Atrial Fibrillation via Risk Factor Modification	25
Exercise Preconditioning as a Cardioprotective Phenotype	25
Novel Anatomic Predictors of New Persistent Left Bundle Branch Block After Evolut Transcatheter Aortic Valve Implantation	25
N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study o	25
Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry)	25
Temporal Changes in Hypertensive Disorders of Pregnancy and Impact on Cardiovascular and Obstetric Outcomes	25
Trends in Acute Myocarditis Related Pediatric Hospitalizations in the United States, 2007–2016	25
Temporal Trends and Outcomes of Left Ventricular Aneurysm After Acute Myocardial Infarction	25
Timing and Outcomes of Percutaneous Coronary Intervention in Patients Who Underwent Transcatheter Aortic Valve Implantation	24
Assessment of the Modified CHA2DS2VASc Risk Score in Predicting Mortality in Patients Hospitalized With COVID-19	24
Outcomes and Hospital Utilization in Patients With Papillary Muscle Rupture Associated With Acute Myocardial Infarction	24
Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel	24
Racial and Socioeconomic Disparities in Cardiotoxicity Among Women With HER2-Positive Breast Cancer	23
Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial)	23
Meta-Analysis Evaluating the Effects of Renin-Angiotensin-Aldosterone System Blockade on Outcomes of Heart Failure With Preserved Ejection Fraction	23
Meta-Analysis Comparing Catheter-Directed Thrombolysis Versus Systemic Anticoagulation Alone for Submassive Pulmonary Embolism	22
Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations	22
Meta-analysis Comparing Outcomes in Patients With and Without Cardiac Injury and Coronavirus Disease 2019 (COVID 19)	22
Relation of Advanced Interatrial Block to Risk of Atrial Fibrillation and Stroke	22
Comparison of Outcomes of Coronary Revascularization for Acute Myocardial Infarction in Men Versus Women	22
Basal Ventricular Septal Hypertrophy in Systemic Hypertension	22
Comparison of Characteristics and Outcomes of Patients With Acute Myocardial Infarction With Versus Without Coronarvirus-19	22
Observed versus Expected Ischemic and Bleeding Events Following Left Atrial Appendage Occlusion	22
Overview of Aspirin and Platelet Biology	22
Inflammatory Markers and Risk of Heart Failure With Reduced to Preserved Ejection Fraction	22
Meta-Analysis of Valve-in-Valve Transcatheter Aortic Valve Implantation Versus Redo-surgical Aortic Valve Replacement in Failed Bioprosthetic Aortic Valve	21
Long-Term Outcomes of Acute Myocardial Infarction With Concomitant Cardiogenic Shock and Cardiac Arrest	21
Meta-analysis of the Effect of Colchicine on Mortality and Mechanical Ventilation in COVID-19	21
Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis	21
Closing Gaps in Lifestyle Adherence for Secondary Prevention of Coronary Heart Disease	21

Meta-Analysis of Prevalence and Risk Factors for Cognitive Decline and Improvement After Transcatheter Aortic Valve Implantation	21
Very High High-Density Lipoprotein Cholesterol Levels and Cardiovascular Mortality	21
Pericardial Involvement in Cancer	21
Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)	21
Efficacy of Coronary Sinus Reducer in Patients With Non-revascularized Chronic Total Occlusions	21
Functional Tricuspid Regurgitation and Right Atrial Remodeling in Heart Failure With Preserved Ejection Fraction	20
Relation of Low Lymphocyte Count to Frailty and its Usefulness as a Prognostic Biomarker in Patients >65 Years of Age With Acute Coronary Syndrome	20
Digoxin Use in Cardiac Amyloidosis	20
Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents E	20
Normative Reference Values of Cardiac Output by Pulsed-Wave Doppler Echocardiography in Adults	20
Incidence and Mortality Trends of Atrial Fibrillation/Atrial Flutter in the United States 1990 to 2017	20
Coronary Artery Disease as the Cause of Sudden Cardiac Death Among Victims < 50 Years of Age	20
A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19	20
Impact of Sustained Weight Loss on Cardiometabolic Outcomes	20
Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Bioprosthetic Heart Valves	19
Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial Fibrillation	19
Frequency and Significance of Coronary Artery Disease and Myocardial Bridging in Patients With Hypertrophic Cardiomyopathy	19
Incidence of Myopericarditis and Myocardial Injury in Coronavirus Disease 2019 Vaccinated Subjects	19
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy	19
Contemporary National Trends and Outcomes of Pulmonary Embolism in the United States	19
Gaps and Disparities in Primary Prevention Statin Prescription During Outpatient Care	19
Impact of Combined Pre and Postcapillary Pulmonary Hypertension on Survival after Transcatheter Aortic Valve Implantation	19
Meta-Analysis of Point-of-Care Lung Ultrasonography Versus Chest Radiography in Adults With Symptoms of Acute Decompensated Heart Failure	19
Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19	18
Influence of Body Weight and Diabetes Mellitus in Patients With Pulmonary Hypertension	18
Influenza Vaccination and Outcome in Heart Failure	18
Ventricular Fibrillation Storm in Coronavirus 2019	18
Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion	18
Prognostic Implications of Significant Isolated Tricuspid Regurgitation in Patients With Atrial Fibrillation Without Left-Sided Heart Disease or Pulmonary Hypertension	18
Usefulness of the American Heart Association's Ideal Cardiovascular Health Measure to Predict Long-term Major Adverse Cardiovascular Events (From the Heart SCORE Study)	18
No Reduction of ST-segment Elevation Myocardial Infarction Admission in Taiwan During Coronavirus Pandemic	18
Sex-Specific Differences in Etiology and Prognosis in Patients With Significant Tricuspid Regurgitation	18
Impact of Arrhythmias on Hospitalizations in Patients With Cardiac Amyloidosis	18
Redo-Transcatheter Aortic Valve Implantation Using the SAPIEN 3/Ultra Transcatheter Heart Valves—Expert Consensus on Procedural Planning and Techniques	18
Prevalence and Long-term Outcomes of Patients with Coronary Artery Ectasia Presenting with Acute Myocardial Infarction	18
Effect of Physical Exercise Training in Patients With Chagas Heart Disease (from the PEACH STUDY)	18
Risk of Cardiovascular Events After COVID-19	18
Pet Ownership and Cardiovascular Health in the US General Population	18
Meta-Analysis of Usefulness of Cerebral Embolic Protection During Transcatheter Aortic Valve Implantation	18
Aspirin for Primary Prevention of Cardiovascular Disease in the 21st Century: A Review of the Evidence	17
Metoprolol Versus Carvedilol in Patients With Heart Failure, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, and Renal Failure	17
Impact of Frailty on Mortality, Readmissions, and Resource Utilization After TAVI	17
Prognostic Impact of Underweight (Body Mass Index <20 kg/m2) in Patients With Severe Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation or Surgical Aortic Valve Replacement (f	17
Relation of Frailty to Outcomes After Catheter Ablation of Atrial Fibrillation	17
Trends in Outcomes of Transcatheter and Surgical Aortic Valve Replacement in the United States (2012–2017)	17
Relation of Bariatric Surgery to Inpatient Cardiovascular Outcomes (from the National Inpatient Sample)	17
Prognostic Value of N-Terminal Pro-form B-Type Natriuretic Peptide in Patients With Moderate Aortic Stenosis	17
Comparison of Late Cardiac Death and Myocardial Infarction Rates in Women Vs Men With ST-Elevation Myocardial Infarction	17
Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Inves	17
Coronary Artery Disease Without Standard Cardiovascular Risk Factors	17
Non-Vitamin K Antagonist Oral Anticoagulant for Atrial Fibrillation in Obese Patients	17
Mortality Risk Assessment Using CHA(2)DS(2)-VASc Scores in Patients Hospitalized With Coronavirus Disease 2019 Infection	17
Associations Between Socioeconomic Context and Congenital Heart Disease Related Outcomes in Adolescents and Adults	17
Comparison of Frequency of Vascular Complications With Ultrasound-Guided Versus Fluroscopic Roadmap-Guided Femoral Arterial Access in Patients Who Underwent Transcatheter Aortic Valve Implantation	17
Effect of Earlier Atrioventricular Valve Intervention on Survival After the Fontan Operation	17
Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT])	16
Meta-analysis of Incidence, Predictors and Consequences of Clinical and Subclinical Bioprosthetic Leaflet Thrombosis After Transcatheter Aortic Valve Implantation	16
Trends in Cardiovascular Deaths Among Young Adults in the United States, 1999 to 2018	16
Meta-analysis Comparing Direct Oral Anticoagulants Versus Vitamin K Antagonists After Transcatheter Aortic Valve Implantation	16
Futility Risk Model for Predicting Outcome After Transcatheter Aortic Valve Implantation	16
Long-Term Prognostic Value of the Society of Thoracic Surgery Risk Score in Patients Undergoing Transcatheter Aortic Valve Implantation (From the OCEAN-TAVI Registry)	16
Admissions Rate and Timing of Revascularization in the United States in Patients With Non-ST-Elevation Myocardial Infarction	16
A Meta-Analysis of Cardiovascular Outcomes in Patients With Hypercholesterolemia Treated With Inclisiran	16
Impact Of Cirrhosis On 90-Day Outcomes After Percutaneous Coronary Intervention (from A Nationwide Database)	16
Hypertrophic Cardiomyopathy and Sudden Death Initially Identified at Autopsy	16
Meta-analysis of Dual Antiplatelet Therapy Versus Monotherapy With P2Y12 Inhibitors in Patients After Percutaneous Coronary Intervention	16
Impact and Determinants of High-Sensitivity Cardiac Troponin-T Concentration in Patients With COVID-19 Admitted to Critical Care	16
Comparing Major Bleeding Risk in Outpatients With Atrial Fibrillation or Flutter by Oral Anticoagulant Type (from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excell	16
Optimization of GRACE Risk Stratification by N-Terminal Pro-B-type Natriuretic Peptide Combined With D-Dimer in Patients With Non-ST-Elevation Myocardial Infarction	16
Artificial Intelligence-Enabled Electrocardiography to Screen Patients with Dilated Cardiomyopathy	15
Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York	15
Meta-Analysis Comparing Outcomes of Therapies for Patients With Central Sleep Apnea and Heart Failure With Reduced Ejection Fraction	15
Efficiency, Safety, and Quality of Life After Transcatheter Aortic Valve Implantation Performed With Moderate Sedation Versus General Anesthesia	15
Features of Sitosterolemia in Children	15
Effectiveness of the 40-Minute Handmade Manikin Program to Teach Hands-on Cardiopulmonary Resuscitation at School Communities	15
Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction	15
Radiotherapy in Patients With a Cardiac Implantable Electronic Device	15
Usefulness of Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina Pectoris	15
Relation of Atrial Fibrillation to Cognitive Decline (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study)	15
Right Ventricular Myocardial Work Characterization in Patients With Pulmonary Hypertension and Relation to Invasive Hemodynamic Parameters and Outcomes	15

Meta-Analysis Comparing Percutaneous to Surgical Access in Trans-Femoral Transcatheter Aortic Valve Implantation	15
Meta-Analysis of Nonalcoholic Fatty Liver Disease and Incident Heart Failure	15
Impact of Charlson Co-Morbidity Index Score on Management and Outcomes After Acute Coronary Syndrome	15
Risk of Lifetime Psychiatric Morbidity in Adults With Atrial Septal Defect (from a Nation-Wide Cohort)	15
Objectively Measured Physical Activity and the Risk of Atrial Fibrillation (from the REGARDS Study)	15
Prognostic Implications of Increased Right Ventricular Wall Tension in Secondary Tricuspid Regurgitation	15
Impact of Diabetes Mellitus on Stroke and Survival in Patients With Atrial Fibrillation	15
Relation of Neighborhood Disadvantage to Heart Failure Symptoms and Hospitalizations	14
Nationwide Frequency, Sequential Trends, and Impact of Co-morbid Mental Health Disorders on Hospitalizations, Outcomes, and Healthcare Resource Utilization in Adult Congenital Heart Disease	14
Meta-Analysis Comparing P2Y12 Inhibitors in Acute Coronary Syndrome	14
Spontaneous Coronary Artery Dissection and Menopause	14
Impact of Predilatation Prior to Transcatheter Aortic Valve Implantation With the Self-Expanding Acurate neo Device (from the Multicenter NEOPRO Registry)	14
COVID-19, POCUS, and Takotsubo	14
Contemporary Trends in Native Valve Infective Endocarditis in United States (from the National Inpatient Sample Database)	14
Long-Term Outcome of Pericardial Drainage in Cases of Chronic, Large, Hemodynamically Insignificant, C-Reactive Protein Negative, Idiopathic Pericardial Effusions	14
Characteristics of COVID-19 Myocarditis With and Without Multisystem Inflammatory Syndrome	14
Continuous Thermodilution Method to Assess Coronary Flow Reserve	14
Effect of Recruitment of Acute Coronary Collaterals on In-Hospital Mortality and on Left Ventricular Function in Patients Presenting With ST Elevation Myocardial Infarction	14
Usefulness of Global Longitudinal Strain to Predict Heart Failure Progression in Patients With Nonobstructive Hypertrophic Cardiomyopathy	14
Meta-Analysis of Randomized Clinical Trials Comparing the Impact of Implantable Loop Recorder Versus Usual Care After Ischemic Stroke for Detection of Atrial Fibrillation and Stroke Risk	14
Electrolyte Abnormalities in Patients Presenting With Ventricular Arrhythmia (from the LYTE-VT Study)	14
Is Increased Sleep Responsible for Reductions in Myocardial Infarction During the COVID-19 Pandemic?	14
Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis	14
Trastuzumab-Related Cardiotoxicity and Cardiac Care in Patients With HER2 Positive Metastatic Breast Cancer	14
Five-Year Outcomes and Prognostic Value of Feature-Tracking Cardiovascular Magnetic Resonance in Patients Receiving Early Prereperfusion Metoprolol in Acute Myocardial Infarction	14
Prognostic Value of Baseline Sarcopenia on 1-year Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation	14
Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 Years	14
Relation of Aspartate Aminotransferase to Alanine Aminotransferase Ratio to Nutritional Status and Prognosis in Patients With Acute Heart Failure	14
Frailty and Post-hospitalization Outcomes in Patients With Heart Failure With Preserved Ejection Fraction	14
Cardiovascular Safety Considerations in the Treatment of Neurogenic Orthostatic Hypotension	13
Meta-analysis Comparing Valve-In-Valve Transcatheter Aortic Valve Implantation With Self-Expanding Versus Balloon-Expandable Valves	13
Prevalence of Acute Pulmonary Embolism at Autopsy in Patients With COVID-19	13
Early Feasibility of Automated Artificial Intelligence Angiography Based Fractional Flow Reserve Estimation	13
Association Between Periodontal Disease and Cardiovascular Disease (from the NHANES)	13
Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial)	13
Predictors of Recurrent Ischemic Events in Patients With ST-Segment Elevation Myocardial Infarction	13
Comparison of Complications and In-Hospital Mortality in Takotsubo (Apical Ballooning/Stress) Cardiomyopathy Versus Acute Myocardial Infarction	13
Meta-Analysis of Transradial vs Transfemoral Access for Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction	13
Relation of First and Total Recurrent Atherosclerotic Cardiovascular Disease Events to Increased Lipoprotein(a) Levels Among Statin Treated Adults With Cardiovascular Disease	13
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study)	13
Meta-Analysis Comparing Distal Radial Artery Approach Versus Traditional for Coronary Procedures	13
Comparison of the Effect of Atrial Fibrillation Detection Algorithms in Patients With Cryptogenic Stroke Using Implantable Loop Recorders	13
Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator Implantation	13
Effect of In Utero Non-Steroidal Anti-Inflammatory Drug Therapy for Severe Ebstein Anomaly or Tricuspid Valve Dysplasia (NSAID Therapy for Fetal Ebstein anomaly)	13
Comparison of Outcomes in Patients With Takotsubo Syndrome With-vs-Without Cardiogenic Shock	13
COVID-19 and Gender Disparities in Pediatric Cardiologists with Dependent Care Responsibilities	13
Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset Analysis	13
Relation of Poor Handgrip Strength or Slow Walking Pace to Risk of Myocardial Infarction and Fatality	13
Prediction Model Using Machine Learning for Mortality in Patients with Heart Failure	13
Comparison of Outcomes of Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Cardiomyopathy in Patients ≤65 Years Versus >65 Years	13
Transcatheter Aortic Valve Implantation During the COVID-19 Pandemic	12
Prognostic Value of Subclinical Coronary Artery Disease in Atrial Fibrillation Patients Identified by Coronary Computed Tomography Angiography	12
Meta-Analysis Comparing Safety and Efficacy of Left Bundle Branch Area Pacing Versus His Bundle Pacing	12
Comparison of Outcomes After Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Versus Reduced Ejection Fraction	12
Six-Month Outcomes for COVID-19 Negative Patients with Acute Myocardial Infarction Before Versus During the COVID-19 Pandemic	12
Contemporary Trends, Predictors and Outcomes of Perforation During Percutaneous Coronary Intervention (From the NCDR Cath PCI Registry)	12
Reasons for Screen Failure for Transcatheter Mitral Valve Repair and Replacement	12
Myopericarditis After COVID-19 Booster Dose Vaccination	12
Impact of High Body Mass Index on Vascular and Bleeding Complications After Transcatheter Aortic Valve Implantation	12
Influence of Influenza Infection on In-Hospital Acute Myocardial Infarction Outcomes	12
Patient and Provider Perspectives on Remote Monitoring of Pacemakers and Implantable Cardioverter-Defibrillators	12
Meta-Analysis of Population Characteristics and Outcomes of Patients Undergoing Pericardiectomy for Constrictive Pericarditis	12
Prognostic Impact of Branch Vessel Involvement on Computed Tomography versus Clinical Presentation of Malperfusion in Patients With Type a Acute Aortic Dissection	12
Declines in Acute Cardiovascular Emergencies During the COVID-19 Pandemic	12
Dual Antiplatelet Therapy De-escalation Strategies	12
Dose of Direct Oral Anticoagulants and Adverse Outcomes in Asia	12
Natural History and Disease Progression of Early Cardiac Amyloidosis Evaluated by Echocardiography	12
Pulmonary Embolism in Patients Hospitalized With COVID-19 (From a New York Health System)	12
Impact of Active and Historical Cancer on Short- and Long-Term Outcomes in Patients With Acute Myocardial Infarction	12
Sports Participation and Exercise Restriction in Children with Isolated Bicuspid Aortic Valve	12
Barriers and Facilitators of Palliative Care and Advance Care Planning in Adults With Congenital Heart Disease	12
Procedural and Short-Term Outcomes of Percutaneous Left Atrial Appendage Closure in Patients With Cancer	12
Left Ventricular End-Systolic Dimension and Outcome in Patients With Heart Failure Undergoing Percutaneous MitraClip Valve Repair for Secondary Mitral Regurgitation	12
The Effect of Anticoagulation Use on Mortality in COVID-19 Infection	12
Meta-analysis Comparing Outcomes of Self-Expanding Versus Balloon-Expandable Valves for Transcatheter Aortic Valve Implantation	12
Effect of Adenotonsillectomy on Cardiac Function in Children Age 5-13 Years With Obstructive Sleep Apnea	11
Meta-analysis Evaluating the Use of Statins to attenuate Cardiotoxicity in Cancer Patients receiving Anthracyclines and Trastuzumab-based Chemotherapy	11
dST-Tiso Interval, a Novel Electrocardiographic Marker of Ventricular Arrhythmia Inducibility in Individuals With Ajmaline-Induced Brugada Type I Pattern	11
Long-Term Outcomes Stratified by Body Mass Index in Patients Undergoing Transcatheter Aortic Valve Implantation	11
Analysis of Adverse Events Related to Impella Usage (from the Manufacturer and User Facility Device Experience and National Inpatient Sample Databases)	11
Impact of Gender on Transcatheter Aortic Valve Implantation Outcomes	11
Distinctive Hypertrophic Cardiomyopathy Anatomy and Obstructive Physiology in Patients Admitted With Takotsubo Syndrome	11
Prediction of 1-Year Mortality from Acute Myocardial Infarction Using Machine Learning	11
Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation	11
Hemodynamic Profiles of Shock in Patients With COVID-19	11
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair	11
Frequency of Reduced Left Ventricular Contractile Efficiency and Discoordinated Myocardial Relaxation in Patients Aged 16 to 21 Years With Type 1 Diabetes Mellitus (from the Emerald Study)	11
Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy	11
Impact of Malnutrition on Outcomes Following Transcatheter Aortic Valve Implantation (from a National Cohort)	11
Meta-analysis Comparing Early Outcomes Following Transcatheter Aortic Valve Implantation With the Evolut Versus Sapien 3 Valves	11
Meta-Analysis Comparing the Frequency of Carotid Artery Stenosis in Patients With Atrial Fibrillation and Vice Versa	11
Phenotyping Left Ventricular Obstruction With Postprandial Re-Test Echocardiography in Hypertrophic Cardiomyopathy	11
What Causes Hypertrophic Cardiomyopathy?	11
Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine	11
Comparison of Different Anticoagulation Regimens Regarding Maternal and Fetal Outcomes in Pregnant Patients With Mechanical Prosthetic Heart Valves (from the Multicenter ANATOLIA-PREG Registry)	11